In addition, Antagomir-103-3p inhibited FASN and ACSL1 mRNA levels and FASN and ACSL1 expression in liver tissues from the mice with NAFLD while promoting ACOX1 mRNA levels and ACOX1 expression (Fig. 3D). Here, ACOX1 is linked to metabolic dysfunction-associated steatotic liver disease.